Congenital disorder of glycosylation
Congenital disorder of glycosylation (CDG) is a group of rare genetic disorders that affect the process of glycosylation, which is the attachment of sugar molecules to proteins and lipids. This process is crucial for the proper functioning of many proteins and lipids in the body. CDGs can lead to a wide range of health problems, including developmental delays, neurological disorders, and organ dysfunction.
Classification[edit | edit source]
CDGs are classified based on the specific step in the glycosylation pathway that is affected. The two main types are:
- CDG-I: Disorders that affect the initial steps of glycosylation in the endoplasmic reticulum.
- CDG-II: Disorders that affect the processing of glycoproteins in the Golgi apparatus.
Symptoms[edit | edit source]
The symptoms of CDGs can vary widely depending on the specific type and severity of the disorder. Common symptoms include:
- Developmental delay
- Intellectual disability
- Seizures
- Hypotonia
- Liver disease
- Coagulopathy
- Failure to thrive
Diagnosis[edit | edit source]
Diagnosis of CDGs typically involves a combination of clinical evaluation, biochemical testing, and genetic testing. Biochemical tests may include analysis of serum transferrin isoforms, which can reveal abnormalities in glycosylation.
Treatment[edit | edit source]
There is currently no cure for CDGs, and treatment is primarily supportive and symptomatic. Management may include:
- Physical therapy
- Occupational therapy
- Speech therapy
- Nutritional support
- Management of specific symptoms such as seizures or liver disease
Prognosis[edit | edit source]
The prognosis for individuals with CDGs varies widely depending on the specific type and severity of the disorder. Some individuals may have mild symptoms and a normal lifespan, while others may have severe, life-threatening complications.
Research[edit | edit source]
Ongoing research is focused on better understanding the underlying mechanisms of CDGs, developing new diagnostic methods, and exploring potential treatments.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Template:Congenital disorders of glycosylation
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD